Search

Your search keyword '"Lee, Jun-Young"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Lee, Jun-Young" Remove constraint Author: "Lee, Jun-Young" Topic mild cognitive impairment Remove constraint Topic: mild cognitive impairment
35 results on '"Lee, Jun-Young"'

Search Results

2. Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.

3. Exploring transfer effects on memory and its neural mechanisms through a computerized cognitive training in mild cognitive impairment: randomized controlled trial.

4. Neuroanatomical and neurocognitive correlates of delusion in Alzheimer's disease and mild cognitive impairment.

5. The Effect of Subsyndromal Symptoms of Depression and White Matter Lesions on Disability for Individuals with Mild Cognitive Impairment

8. Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults.

9. Multiple Cognitive and Behavioral Factors Link Association Between Brain Structure and Functional Impairment of Daily Instrumental Activities in Older Adults.

10. Late-Life Physical Activities Moderate the Relationship of Amyloid-β Pathology with Neurodegeneration in Individuals Without Dementia.

11. Self- and informant-reported cognitive functioning and awareness in subjective cognitive decline, mild cognitive impairment, and very mild Alzheimer disease.

12. Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease.

13. High burden of cerebral white matter lesion in 9 Asian cities.

14. Effects of Chronic Tinnitus on Metabolic and Structural Changes in Subjects With Mild Cognitive Impairment.

15. Long-Term Exposure to PM10 and in vivo Alzheimer's Disease Pathologies.

16. Proteasome Activity in the Plasma as a Novel Biomarker in Mild Cognitive Impairment with Chronic Tinnitus.

17. Cognitive Reserve, Leisure Activity, and Neuropsychological Profile in the Early Stage of Cognitive Decline.

18. Plasma Clusterin as a Potential Link Between Diabetes and Alzheimer Disease.

20. Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic Practice.

21. Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer’s Disease in Mild Cognitive Impairment.

22. Differences in knowledge of dementia among older adults with normal cognition, mild cognitive impairment, and dementia: A representative nationwide sample of Korean elders.

23. Development and Validation of the Rappel Indicé-24: Behavioral and Brain Morphological Evidence.

24. Mortality rates and predictors in community-dwelling elderly individuals with cognitive impairment: an eight-year follow-up after initial assessment.

25. Differences in Prefrontal, Limbic, and White Matter Lesion Volumes According to Cognitive Status in Elderly Patients with First-Onset Subsyndromal Depression.

26. Effect of Cognitive Training in Fully Immersive Virtual Reality on Visuospatial Function and Frontal-Occipital Functional Connectivity in Predementia: Randomized Controlled Trial.

27. Association of carotid and intracranial stenosis with Alzheimer's disease biomarkers.

28. Cognitive Improvement in Older Adults with Mild Cognitive Impairment: Evidence from a Multi-Strategic Metamemory Training.

29. Interactions between subjective memory complaint and objective cognitive deficit on memory performances.

31. Physical Frailty and Amyloid-β Deposits in the Brains of Older Adults with Cognitive Frailty.

32. Lower cognitive function attenuates the convergence between self‐ratings and observer ratings of depressive symptoms in late‐life cognitive impairment.

33. Clinical and biological subtypes of late-life depression.

34. A quick test of cognitive speed in older adults with Alzheimer's disease and mild cognitive impairment: A preliminary behavioral and brain imaging study.

35. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer’s disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.

Catalog

Books, media, physical & digital resources